Although DSP cannot directly determine which cell type is expressing a target protein, a prior study has demonstrated that both tumor cells and immune cells can express components of the MHC II pathway, and likely both facilitate antitumor immunity in TNBC34. This evidence concerns the gene DSP and neoplasm.